Mustafa Özdoğan

3.3k citations
115 papers · 2.6k · 1 hit paper · h-index 24

Impact in

  • Oncology top 5%
    • Inflammatory Biomarkers in Disease Prognosis
    • Cancer Immunotherapy and Biomarkers
    • Cancer survivorship and care

Papers in

    • Cancer Treatment and Pharmacology 5
    • Cancer Immunotherapy and Biomarkers 4
    • Lung Cancer Research Studies 3
    • Breast Cancer Treatment Studies 5

Mustafa Özdoğan

110 papers receiving 2.5k citations

Mustafa Özdoğan's Hit Papers

Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial 2021 · 488 citations
4880+1+3Years since publication100200300400

Peers

Mustafa Özdoğan
Comparison fields: 5 of 129
  • Oncology 854
  • Internal Medicine 51
  • Endocrinology, Diabetes and Metabolism 237
  • Surgery 507
  • Cancer Research 146
Replace Nikolaos F. Arkadopoulos with:
Nikolaos F. Arkadopoulos Greece
Manuel Hernández‐Guerra Spain
Aric Josun Hui Hong Kong
Paul Carter United Kingdom
Rune Erichsen Denmark
Laure Elens Belgium
Tien C. Ko United States
Jessica Y. L. Ching Hong Kong
Haiyan Wang China
Ghazi S Zaatari Lebanon
Mustafa Özdoğan relative to Nikolaos F. Arkadopoulos Greece Nikolaos F. Arkadopoulos's profile →
Citations per field
00.5×2×2.6×
Nikolaos F. Arkadopoulos · 1×
Citations per year

Countries citing papers authored by Mustafa Özdoğan

Since Specialization
Citations

This map shows the geographic impact of Mustafa Özdoğan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mustafa Özdoğan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mustafa Özdoğan more than expected).

Fields of papers citing papers by Mustafa Özdoğan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mustafa Özdoğan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mustafa Özdoğan. The network helps show where Mustafa Özdoğan may publish in the future.

Co-authors

The 25 scholars most cited alongside Mustafa Özdoğan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mustafa Özdoğan Line = papers co-authored together Mustafa Özdoğan links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 115 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial
Hit paper breakdown →
2021488
2 2004248
3 2005245
4 2005110
5 200489
6
Curcumin (Turmeric) and cancer.
201774
7 200470
8 200867
9 200265
10 200651
11 199741
12 200541
13 200338
14
Ganoderma Lucidum (Reishi Mushroom) and cancer.
201736
15 200434
16 200434
17 200734
18 200630
19 200930
20 200129

About Mustafa Özdoğan

Mustafa Özdoğan is a scholar working on Oncology, Cancer Research, Pulmonary and Respiratory Medicine, Endocrinology, Diabetes and Metabolism and Surgery, having authored 115 papers that have together received 2.6k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (5 papers), Breast Cancer Treatment Studies (5 papers), Cancer Immunotherapy and Biomarkers (4 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (3 papers), Lung Cancer Research Studies (3 papers), Pain Management and Opioid Use (3 papers), Vitamin D Research Studies (3 papers) and Cervical Cancer and HPV Research (3 papers). The work is most often cited by research in Oncology (854 citations), Internal Medicine (51 citations), Endocrinology, Diabetes and Metabolism (237 citations), Surgery (507 citations) and Cancer Research (146 citations). Mustafa Özdoğan has collaborated with scholars based in Türkiye, United Kingdom and Greece. Frequent co-authors include Erkan Çoban, Gokhan Yazicioglu, Ayşen TİMURAĞAOĞLU, Burhan Savaş, Hakan Sat Bozcuk, Mehmet Artaç, Mustafa Samur, Erdinç Nayır, Hakan Sat Bozcuk and Hasan Huseyin Mutlu. Their work appears in journals such as International Journal of Clinical Practice, Viruses, The International Journal of Biological Markers, Journal of Human Hypertension and Supportive Care in Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact